Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
REPREO
2 other identifiers
interventional
214
1 country
12
Brief Summary
Out of 30,000 new cases per year in France, 30% of epileptic patients are drug-resistant. Neurosurgery, which consists in resecting the epileptogenic zone, is the only chance of cure. In the case of temporal epilepsy of the language-dominant hemisphere (TLE), this procedure presents a high risk of increasing cognitive difficulties and may even be contraindicated for this reason alone. The difficulties found are impairments in lexical access (anomia) and verbal memory and affect more than 60% of patients . Preoperative cognitive rehabilitation could influence brain plasticity mechanisms but there are currently no recommendations on this topic. In this context, the investigators have developed a speech rehabilitation procedure specific to the needs of ELTPR patients. They rely on cognitive hypotheses explaining the disorders but also on models of rehabilitation-induced neural plasticity likely to improve cognitive reserve before surgery. The investigators hypothesize that preoperative cognitive language rehabilitation in ELTPR patients may decrease surgical risk and improve postoperative language prognosis. The primary objective is to demonstrate the protective efficacy of preoperative speech rehabilitation on language performance postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2022
CompletedFirst Posted
Study publicly available on registry
November 8, 2022
CompletedStudy Start
First participant enrolled
March 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2027
July 18, 2024
July 1, 2024
4 years
October 25, 2022
July 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Effect of rehabilitation on immediate postoperative performances
Number of images quoted
Day 7 after surgery
Secondary Outcomes (14)
Impact of rehabilitation on long-term postoperative performance
6 months after surgery
Impact of rehabilitation on immediate on standardized language tests
Day 7 after surgery
Impact of rehabilitation on long-term postoperative performance on standardized language tests
6 months after surgery
Impact of preoperative rehabilitation on verbal memory
Day 7 after surgery
Impact of preoperative rehabilitation on verbal memory
6 months after surgery
- +9 more secondary outcomes
Study Arms (2)
Control
OTHERPatients will have speech therapy assessment in addition to standard care.
Experimental
EXPERIMENTALPatients will have speech therapy assessment and intensive speech rehabilitation
Interventions
Patients will be followed by an speech therapist
Eligibility Criteria
You may qualify if:
- Patient 16 years of age and older,
- Patient whose epileptogenic area involves the temporal structures of the hemisphere specialized for language,
- Patient whose hemispheric specialization for language is known
- Patient willing to undergo resective surgery such as anterior temporal lobectomy or resection in the temporal lobe involving the hippocampus and/or the baso-temporal language area and whose planned surgery date is compatible with the performance of the study,
- Patient with a known NTB score
- Patient who has signed an informed consent or patient whose parents or legal guardians have signed the informed consent (or a single parent or legal guardian if applicable)
- Patient whose first language is French (1st language learned by the patient),
- Patient declaring to be familiar with the use of a computer and having access to an internet connection from home
- Patient affiliated or benefiting from a social security system.
You may not qualify if:
- Patient with a speech disorder that may impair intelligibility and compromise the use of the interface;
- Patient with an uncorrected hearing impairment,
- Patients with a total intelligence quotient (IQ) \<70 (assessed in the context of care, in the year preceding the surgical procedure)
- Patients who are pregnant, nursing, deprived of liberty, under guardianship or curatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
Service EFSN - Hôpital Pellegrin
Bordeaux, France
Service de Neurologie de l'Epilepsie - CHU Grenoble-Alpes
Grenoble, France
Département de Neurophysiologie Clinique - Hôpital Roger Salengro - CHU Lille
Lille, France
Hôpital Neurologique Pierre Wertheimer- Service de Neurologie Fonctionnelle et Epileptologie - Hospices Civils Lyon
Lyon, France
Service Epilptologie et Rythmologie Cérébrale
Marseille, France
Service de Neurologie - Hôpital central -CHU Nancy
Nancy, France
Département de Neurologie - Hôpital de la Pitié-Salpêtrière - APHP
Paris, France
Service de Neurochirurgie -GHU Sainte-Anne
Paris, France
Service de Neurologie - Fondation ophtalmologique de Rothschild - Fondation Rothschild
Paris, France
Service de Neurologie - CHU de Rennes
Rennes, France
Service de Neurologie - Hôpitaux Universitaires, Hôpital de Hautepierre
Strasbourg, France
Explorations Neurophysiologiques, Pôle des Neurosciences - Hôpital Pierre Paul Riquet, Purpan
Toulouse, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Francois CREMIEUX
AP-HM
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2022
First Posted
November 8, 2022
Study Start
March 30, 2023
Primary Completion (Estimated)
March 30, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
July 18, 2024
Record last verified: 2024-07